A treatment approach considered for certain cancers that have spread to the lining of the abdominal cavity. Suitability depends on the cancer type, extent of disease, overall health and findings from a detailed specialist assessment.
Request a ConsultationCareful evaluation.
Individualised planning.
Cytoreductive surgery (CRS) aims to remove visible tumour deposits from the abdominal cavity. In selected cases, it may be combined with hyperthermic intraperitoneal chemotherapy (HIPEC), in which warmed chemotherapy is circulated within the abdomen during surgery. The approach is not suitable for every patient or every cancer.
Dr. Harish Kumar H’s curriculum vitae lists cytoreductive surgery and HIPEC among his surgical skills. Assessment usually requires review of the diagnosis, scans, previous treatments, distribution of disease and general fitness. A specialist team can then discuss whether this approach or another treatment pathway is appropriate for the individual case.
CRS and HIPEC may be considered for specific cancers involving the peritoneum after careful staging and multidisciplinary review. The likely benefits, risks and alternatives vary with each diagnosis and the extent of disease.
Assessment of selected cases where bowel cancer has spread to the lining of the abdomen.
Review of selected appendiceal cancers and related conditions involving the peritoneal surface.
Evaluation of this uncommon condition, which can involve mucin-producing tumours within the abdomen.
Specialist review of selected cancers that originate in or affect the peritoneal lining.
Assessment of the diagnosis and disease extent to determine whether a specialised treatment approach may be discussed.
Individual review of other tumour types affecting the abdominal lining, based on specialist evidence and suitability.
CRS and HIPEC are complex treatments that require careful selection and coordinated planning. The treatment team weighs the possible benefits against surgical risks, recovery needs and other available options before making a recommendation.
Imaging, pathology, previous treatment details and general fitness are reviewed to understand the extent of disease and whether surgery should be considered.
When appropriate, surgery aims to remove visible tumour deposits. The scope of the operation depends on where the disease is located and what can be safely removed.
HIPEC may be administered during the same operation for selected patients. The decision, drug protocol and overall treatment plan depend on the diagnosis and specialist-team recommendation.